Skip to main content

Find Clinical Trials

Home
Conditions
Non-Hodgkin's Lymphoma

Clinical trial condition

Non-Hodgkin's Lymphoma

Explore clinical trials studying Non-Hodgkin's Lymphoma. Study availability and eligibility vary by location and protocol.

250 public trials 21 recruiting studies

Refine in advanced search Browse all conditions

Non-Hodgkin's Lymphoma trial results

Completed

Evaluation of Approved Weight-Based Dose Compared to Fixed Dose of Plerixafor in Patients With Non-Hodgkin's Lymphoma (NHL) Weighing Less Than 70 Kilograms

NCT01164475

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: City of Hope National Medical Center Duarte, California, United States

University of Colorado Cancer Center Aurora, Colorado, United States

Princess Margaret Hospital Toronto, Ontario, Canada

Samsung Medical Center Seoul, South Korea

View Trial Details

Completed

Long-Term Follow-up Study for Non-Hodgkin's Lymphoma Patients Who Received Study Treatment (Plerixafor or Placebo) in the AMD3100-3101 Study (NCT00103610).

NCT00741325

Conditions: Autologous Transplantation, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Not specified

View Trial Details

Completed

A Pediatric Study of a Plerixafor Containing Regimen In Second Allogeneic Stem Cell Transplantation

NCT01068301

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +25 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Completed

Radioimmunotherapy With 90Y Zevalin for Orbital Lymphoma

NCT00387023

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Use of Topotecan in Patients With Refractory Acute Leukemia

NCT00100477

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
Locations: North Florida/South Georgia Veterans Health System Gainesville, Florida, United States

View Trial Details

Completed

Safety and Efficacy of IDEC-114 in Combination With Rituxan in the Treatment of Non-Hodgkin's Lymphoma

NCT00048555

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Research site Birmingham, Alabama, United States

Research site Tucson, Arizona, United States

Research site Los Angeles, California, United States

Research site Newport Beach, California, United States

View all 22 locations

View Trial Details

Completed

Pegfilgrastim Administered on the Same Day as Chemotherapy in Non-Hodgkin's Lymphoma

NCT00115193

Conditions: Agranulocytosis, Cytopenia, Hematologic Diseases, +13 more
Locations: Not specified

View Trial Details

Completed

Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic Malignancies

NCT00697671

Conditions: Acute Lymphoblastic Leukemia, Bone Marrow Diseases, Chronic Disease, +28 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Completed

SNP-Based Prediction of Oral Mucositis Risk in Patients Receiving Hematopoietic Stem Cell Transplants (HSCT)

NCT01402687

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Digestive System Diseases, +24 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Study of SyB L-0501 in Combination With Rituximab to Treat Relapsed/Refractory Diffuse Large B-Cell Lymphoma

NCT01118845

Conditions: Dendritic Cell Sarcoma, Interdigitating, Diffuse, Mantle Cell Lymphoma, Lymphoma, Follicular Lymphoma, +16 more
Locations: Nagoya, Aichi-ken, Japan

Akita, Japan

Matsuyama, Ehime, Japan

Fukuoka, Japan

View all 25 locations

View Trial Details